Results 211 to 220 of about 27,341 (230)

Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product

Journal of Drug Delivery Science and Technology, 2019
This study aims to develop ezetimibe-loaded solid lipid nanoparticles (SLNs) and compare them with marketed product and drug suspension for dissolution and bioavailability. Ezetimibe-loaded SLNs were fabricated using high pressure homogeniser (HPH).
F. Din, A. Zeb, K. Shah, Zia-ur-Rehman
semanticscholar   +1 more source

Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review

Current Atherosclerosis Reports
E. Olmastroni, Stefano Scotti, F. Galimberti, Sining Xie, M. Casula   +4 more
semanticscholar   +1 more source

Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans

Circulation, 2002
Thomas Sudhop, Dieter Lütjohann, Diane L Tribble   +2 more
exaly  

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus

Circulation, 2018
Robert P Giugliano, Christopher P Cannon, Michael A Blazing   +2 more
exaly  

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

Circulation, 2015
Robert P Giugliano, Christopher P Cannon, Jing Zhou   +2 more
exaly  

Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis

Journal of Clinical Lipidology, 2009
Alawi A Alsheikh-Ali, Richard H Karas
exaly  

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Clinical Therapeutics, 2004
Harold E Bays, Leiv Osé, Diane L Tribble   +2 more
exaly  

Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients

Atherosclerosis, 2015
Olivier S Descamps, Joanne E Tomassini, Adam B Polis   +2 more
exaly  

The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial

Diabetologia, 2014
Toshinari Takamura, Yuki Kita, Shuichi Kaneko   +2 more
exaly  

Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia

American Journal of Cardiovascular Drugs, 2020
Yvette N. Lamb
semanticscholar   +1 more source